The weekly litigation news digest is live. Subscribe now

Process For The Preparation Of Cabazitaxel And Its Intermediates - EP2917192

The patent EP2917192 was granted to Intas Pharmaceuticals on Mar 20, 2019. The application was originally filed on Oct 31, 2013 under application number EP13817744A. The patent is currently recorded with a legal status of "Revoked".

EP2917192

INTAS PHARMACEUTICALS
Application Number
EP13817744A
Filing Date
Oct 31, 2013
Status
Revoked
Aug 21, 2020
Publication Date
Mar 20, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

HOFFMANN EITLENov 29, 2019HOFFMANN EITLEADMISSIBLE

Patent Citations (11) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONCN102060815
DESCRIPTIONCN102285947
DESCRIPTIONUS5847170
DESCRIPTIONUS5962705
INTERNATIONAL-SEARCH-REPORTUS5635531
INTERNATIONAL-SEARCH-REPORTUS5962705
OPPOSITIONCN102285947
OPPOSITIONCN102417491
OPPOSITIONCN102516281
OPPOSITIONUS5962705
OPPOSITIONUS6891050

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents